BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hambrecht-Wiedbusch VS, Gauthier EA, Baghdoyan HA, Lydic R. Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation. Sleep 2010;33:909-18. [PMID: 20614851 DOI: 10.1093/sleep/33.7.909] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Saravanapandian V, Nadkarni D, Hsu SH, Hussain SA, Maski K, Golshani P, Colwell CS, Balasubramanian S, Dixon A, Geschwind DH, Jeste SS. Abnormal sleep physiology in children with 15q11.2-13.1 duplication (Dup15q) syndrome. Mol Autism 2021;12:54. [PMID: 34344470 DOI: 10.1186/s13229-021-00460-8] [Reference Citation Analysis]
2 Filbey WA, Sanford DT, Baghdoyan HA, Koch LG, Britton SL, Lydic R. Eszopiclone and dexmedetomidine depress ventilation in obese rats with features of metabolic syndrome. Sleep 2014;37:871-80. [PMID: 24790265 DOI: 10.5665/sleep.3650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kohlmeier KA, Kristiansen U. GABAergic actions on cholinergic laterodorsal tegmental neurons: implications for control of behavioral state. Neuroscience 2010;171:812-29. [PMID: 20884335 DOI: 10.1016/j.neuroscience.2010.09.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
4 Krystal AD. In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications. Sleep 2010;33:859-60. [PMID: 20614842 DOI: 10.1093/sleep/33.7.859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Garrity AG, Botta S, Lazar SB, Swor E, Vanini G, Baghdoyan HA, Lydic R. Dexmedetomidine-induced sedation does not mimic the neurobehavioral phenotypes of sleep in Sprague Dawley rat. Sleep 2015;38:73-84. [PMID: 25325438 DOI: 10.5665/sleep.4328] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
6 Vanini G, Lydic R, Baghdoyan HA. GABA-to-ACh ratio in basal forebrain and cerebral cortex varies significantly during sleep. Sleep 2012;35:1325-34. [PMID: 23024430 DOI: 10.5665/sleep.2106] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
7 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness. Sleep Med Clin 2010;5:513-28. [PMID: 21278831 DOI: 10.1016/j.jsmc.2010.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
8 Vanini G, Nemanis K, Baghdoyan HA, Lydic R. GABAergic transmission in rat pontine reticular formation regulates the induction phase of anesthesia and modulates hyperalgesia caused by sleep deprivation. Eur J Neurosci 2014;40:2264-73. [PMID: 24674578 DOI: 10.1111/ejn.12571] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
9 Hambrecht-Wiedbusch VS, Mitchell MF, Firn KA, Baghdoyan HA, Lydic R. Benzodiazepine site agonists differentially alter acetylcholine release in rat amygdala. Anesth Analg 2014;118:1293-300. [PMID: 24842176 DOI: 10.1213/ANE.0000000000000201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness: 2012 Update. Sleep Med Clin 2012;7:469-86. [PMID: 23162386 DOI: 10.1016/j.jsmc.2012.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
11 Vanini G, Wathen BL, Lydic R, Baghdoyan HA. Endogenous GABA levels in the pontine reticular formation are greater during wakefulness than during rapid eye movement sleep. J Neurosci 2011;31:2649-56. [PMID: 21325533 DOI: 10.1523/JNEUROSCI.5674-10.2011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
12 Omori K, Kagami Y, Yokoyama C, Moriyama T, Matsumoto N, Masaki M, Nakamura H, Kamasaka H, Shiraishi K, Kometani T, Kuriki T, Huang Z, Urade Y. Promotion of non-rapid eye movement sleep in mice after oral administration of ornithine: Sleep promotion of ornithine. Sleep and Biological Rhythms 2012;10:38-45. [DOI: 10.1111/j.1479-8425.2011.00515.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
13 Allon N, Chapman S, Egoz I, Rabinovitz I, Kapon J, Weissman BA, Yacov G, Bloch-Shilderman E, Grauer E. Deterioration in brain and heart functions following a single sub-lethal (0.8 LCt50) inhalation exposure of rats to sarin vapor: a putative mechanism of the long term toxicity. Toxicol Appl Pharmacol 2011;253:31-7. [PMID: 21419149 DOI: 10.1016/j.taap.2011.03.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
14 Masaki M, Aritake K, Tanaka H, Shoyama Y, Huang ZL, Urade Y. Crocin promotes non-rapid eye movement sleep in mice. Mol Nutr Food Res 2012;56:304-8. [PMID: 22038919 DOI: 10.1002/mnfr.201100181] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
15 Xu XH, Qiu MH, Dong H, Qu WM, Urade Y, Huang ZL. GABA transporter-1 inhibitor NO-711 alters the EEG power spectra and enhances non-rapid eye movement sleep during the active phase in mice. Eur Neuropsychopharmacol 2014;24:585-94. [PMID: 24080505 DOI: 10.1016/j.euroneuro.2013.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hong KB, Park Y, Suh HJ. Sleep-promoting effects of the GABA/5-HTP mixture in vertebrate models. Behav Brain Res 2016;310:36-41. [PMID: 27150227 DOI: 10.1016/j.bbr.2016.04.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
17 Gauthier EA, Guzick SE, Brummett CM, Baghdoyan HA, Lydic R. Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat. Anesthesiology 2011;115:743-53. [PMID: 21857500 DOI: 10.1097/ALN.0b013e31822e9f85] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
18 Cho S, Yoon M, Pae AN, Jin Y, Cho N, Takata Y, Urade Y, Kim S, Kim J, Yang H, Kim J, Kim J, Han J, Shimizu M, Huang Z. Marine polyphenol phlorotannins promote non-rapid eye movement sleep in mice via the benzodiazepine site of the GABAA receptor. Psychopharmacology 2014;231:2825-37. [DOI: 10.1007/s00213-014-3445-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
19 Sonmez AI, Almorsy A, Ramsey LB, Strawn JR, Croarkin PE. Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations. Depress Anxiety 2020;37:747-59. [PMID: 32419335 DOI: 10.1002/da.23038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Nguyen TQ, Liang CL, Marks GA. GABA(A) receptors implicated in REM sleep control express a benzodiazepine binding site. Brain Res 2013;1527:131-40. [PMID: 23835499 DOI: 10.1016/j.brainres.2013.06.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Kohlmeier KA, Christensen MH, Kristensen MP, Kristiansen U. Pharmacological evidence of functional inhibitory metabotrophic glutamate receptors on mouse arousal-related cholinergic laterodorsal tegmental neurons. Neuropharmacology 2013;66:99-113. [PMID: 22381584 DOI: 10.1016/j.neuropharm.2012.02.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
22 Flint RR, Chang T, Lydic R, Baghdoyan HA. GABA(A) receptors in the pontine reticular formation of C57BL/6J mouse modulate neurochemical, electrographic, and behavioral phenotypes of wakefulness. J Neurosci 2010;30:12301-9. [PMID: 20844126 DOI: 10.1523/JNEUROSCI.1119-10.2010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
23 Williams ST, Conte MM, Goldfine AM, Noirhomme Q, Gosseries O, Thonnard M, Beattie B, Hersh J, Katz DI, Victor JD, Laureys S, Schiff ND. Common resting brain dynamics indicate a possible mechanism underlying zolpidem response in severe brain injury. Elife 2013;2:e01157. [PMID: 24252875 DOI: 10.7554/eLife.01157] [Cited by in Crossref: 56] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
24 Becker LA, Penagos H, Flores FJ, Manoach DS, Wilson MA, Varela C. Eszopiclone and Zolpidem Produce Opposite Effects on Hippocampal Ripple Density. Front Pharmacol 2021;12:792148. [PMID: 35087405 DOI: 10.3389/fphar.2021.792148] [Reference Citation Analysis]